PF-05221304 (PF'1304), A LIVER-TARGETED ACETYL-CoA CARBOXYLASE INHIBITOR (ACCI), IN ADULTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DEMONSTRATES ROBUST REDUCTIONS IN LIVER FAT AND ALT - PHASE 2a, DOSE-RANGING STUDY-MedSci.cn

PF-05221304 (PF'1304), A LIVER-TARGETED ACETYL-CoA CARBOXYLASE INHIBITOR (ACCI), IN ADULTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DEMONSTRATES ROBUST REDUCTIONS IN LIVER FAT AND ALT - PHASE 2a, DOSE-RANGING STUDY

Amin, N; Carvajal-Gonzalez, S; Aggarwal, N; Tuthill, T; Inglot, M; Bergman, A; Esler, W

HEPATOLOGY, 2019; 70 (): 21A

科室
- - 订阅+
  - 更多科室
工具
服务